Sigma-Aldrich to Develop Parkinson's Models | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich plans to develop preclinical research models of Parkinson's disease through a research grant from the Michael J. Fox Foundation, the foundation said today.

Sigma Advanced Genetic Engineering (SAGE) will use zinc finger nuclease technology to develop preclinical research models that after around one year of development time it plans to make available to the Parkinson's research community.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.